ReviewBreast cancer research : BCR2021

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer.

Jamie O Brett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.